Company intelligence / Profile preview

Dumex

Shanghai, Shanghai, Chinadumex.com.sg ↗

Ownership: Private
Employees: ~273
Development stage: Other

Overview

Dumex is a leading brand in infant and child nutrition across Asia—especially China and Singapore—now operating as a subsidiary/brand within Groupe Danone. Historically, it was also a major European exporter/manufacturer of branded pharmaceuticals and fermentation antibiotics before its acquisition by larger pharmaceutical groups. No clinical trial results are relevant to its current product line.

Therapeutic areas: Metabolic DisordersInfectious Diseases
Modalities: Infant formula/nutrition productsantibiotics such as BacitracinTetracyclineAmphotericin B
Industry: Food & Nutrition

Partnerships

No major external partnerships disclosed for the current entity. Parent company has broad industry collaborations.

Beyond the preview

Go deeper on Dumex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dumex.

Explore the full profile